Holen Sie sich die Stockscreener-App
6.45
0.47%
0.03
Handel nachbörslich:
6.46
0.010
+0.16%
Schlusskurs vom Vortag:
$6.42
Offen:
$6.4
24-Stunden-Volumen:
280.35K
Relative Volume:
0.92
Marktkapitalisierung:
$174.63M
Einnahmen:
$351.50M
Nettoeinkommen (Verlust:
$-24.90M
KGV:
-7.0384
EPS:
-0.9164
Netto-Cashflow:
$-10.24M
1W Leistung:
+4.88%
1M Leistung:
+0.00%
6M Leistung:
+9.32%
1J Leistung:
+2.22%
1-Tages-Spanne:
$6.12
$6.46
1-Wochen-Bereich:
$6.12
$6.5477
52-Wochen-Spanne:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.45 | 170.84M | 351.50M | -24.90M | -10.24M | -0.9164 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INGN|Inogen Inc|Price:6.150|Chg%:-0.170 - TradingKey
Inogen Inc (INGN) Balance Sheet - TradingKey
TradingKey - TradingKey
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inogen stock trades quietly as investors weigh margin pressure and restructuring impact - Ad-hoc-news.de
Inogen to report Q2 2026 results after market close, host conference call - Bitget
Inogen to report second quarter 2026 results on August 6 - scanx.trade
Press Release: Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
Inogen Inc (INGN) Holds Steady Near Support as Consolidation ContinuesMFI Divergence - dars.gov.et
Inogen (INGN) Stifel 2024 Healthcare Conference Summary - Quartr
Form 4 Inogen Inc For: 9 July By Investing.com - Investing.com Nigeria
Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026 - Stock Titan
Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report - Stock Titan
INGN Q1 2026 Earnings: EPS Falls Short of EstimatesPre-Earnings Setup - po-news-eg.net
Inogen Inc (INGN) executive sells 10,938 shares in planned trade - Stock Titan
Inogen Inc (INGN) Slips Slightly Amidst Range-Bound TradingPrice Surge Stocks - dars.gov.et
INGNInogen Inc Volatility & Greeks - Finviz
Inogen (INGN) Proxy Filing Summary - Quartr
Inogen Appoints New Chief Operating Officer for Growth - The Globe and Mail
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer - BioSpace
Inogen appoints Andy Reding as chief operating officer - Investing.com
[144] Inogen Inc SEC Filing - Stock Titan
Inogen (INGN) Appoints New COO to Enhance Operational Efficiency - GuruFocus
Inogen appoints Andy Reding as chief operating officer By Investing.com - Investing.com India
Inogen Appoints Reding to New COO Role - Moomoo
Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package - Stock Titan
Inogen, Inc. Financial Disclosures & Filings - TradingView
Inogen Inc (INGN) Q1 2026 Earnings: EPS Miss Weighs on Shares as Revenue Details Remain DisclosedEarnings Surprise Score - dars.gov.et
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Here's why you should retain Inogen stock in your portfolio for now - MSN
Inogen, Inc. Actuals & Estimates (NASDAQ:INGN) - TradingView
Inogen, Inc. Actuals & Estimates (LSX:A1XB32) - TradingView
Inogen, Inc. Actuals & Estimates (SWB:6IO) - TradingView
Enterprise value to EBIT forward of Inogen, Inc – NASDAQ:INGN - TradingView
Price to sales forward of Inogen, Inc – NASDAQ:INGN - TradingView
Enterprise value to revenue forward of Inogen, Inc – NASDAQ:INGN - TradingView
Inogen, Inc. Actuals & Estimates (GETTEX:6IO) - TradingView
INGN Forecast — Price Target — Prediction for 2027 - TradingView
6IO Forecast — Price Target — Prediction for 2027 - TradingView
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Zacks Investment Research
INGN Q1 2026 Earnings: EPS Misses Estimates, Shares Edge HigherEstimate Dispersion - dars.gov.et
Precision Trading with Inogen Inc (INGN) Risk Zones - Stock Traders Daily
Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):